Literature DB >> 20086009

Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC.

Suparna Mallik1, Wenbin Yang, Eric M Norstrom, James A Mastrianni.   

Abstract

Prion diseases result from the accumulation of a misfolded isoform (PrP(Sc)) of the normal host prion protein (PrP(C)). PrP(Sc) propagates by templating its conformation onto resident PrP(C) to generate new PrP(Sc). Although the nature of the PrP(Sc)-PrP(C) complex is unresolved, certain segments or specific residues are thought to feature critically in its formation. The polymorphic residue 129 is one such site under considerable study. We combined transmission studies with a novel live cell yeast-based fluorescence resonance energy transfer (FRET) system that models the molecular association of PrP in a PrP(Sc)-like state, as a way to explore the role of residue 129 in this process. We show that a reduction in efficiency of prion transmission between donor PrP(Sc) and recipient PrP(C) that are mismatched at residue 129 correlates with a reduction in FRET between PrP-129M and PrP-129V in our yeast model. We further show that this effect depends on the different secondary structure propensities of Met and Val, rather than the specific amino acids. Finally, introduction of the disease-associated P101L mutation (mouse- equivalent) abolished FRET with wild-type mouse PrP, whereas mutant PrP-P101L displayed high FRET with homologous PrP-P101L, as long as residue 129 matched. These studies provide the first evidence for a physical alteration in the molecular association of PrP molecules differing in one or more residues, and they further predict that the different secondary structure propensities of Met and Val define the impaired association observed between PrP(Sc) and PrP(C) mismatched at residue 129.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20086009      PMCID: PMC2838318          DOI: 10.1074/jbc.M109.058107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  The prion diseases.

Authors:  J A Mastrianni; R P Roos
Journal:  Semin Neurol       Date:  2000       Impact factor: 3.420

2.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.

Authors:  G C Telling; T Haga; M Torchia; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

3.  De novo generation of a PrPSc-like conformation in living cells.

Authors:  J Ma; S Lindquist
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

4.  Codon 129 changes in the prion protein gene in Caucasians.

Authors:  F Owen; M Poulter; J Collinge; T J Crow
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

5.  Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.

Authors:  Carsten Korth; Kiyotoshi Kaneko; Darlene Groth; Norbert Heye; Glenn Telling; James Mastrianni; Piero Parchi; Pierluigi Gambetti; Robert Will; James Ironside; Cornelia Heinrich; Patrick Tremblay; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

6.  Prediction of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

Review 7.  The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies.

Authors:  R J Kascsak; M Tonna-DeMasi; R Fersko; R Rubenstein; R I Carp; J M Powers
Journal:  Dev Biol Stand       Date:  1993

8.  Inherited prion disease (PrP lysine 200) in Britain: two case reports.

Authors:  J Collinge; M S Palmer; T Campbell; K C Sidle; D Carroll; A Harding
Journal:  BMJ       Date:  1993-01-30

9.  Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.

Authors:  G C Telling; M Scott; K K Hsiao; D Foster; S L Yang; M Torchia; K C Sidle; J Collinge; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC.

Authors:  Laszlo L P Hosszu; Graham S Jackson; Clare R Trevitt; Samantha Jones; Mark Batchelor; Daljit Bhelt; Kanella Prodromidou; Anthony R Clarke; Jonathan P Waltho; John Collinge
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  8 in total

1.  Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay.

Authors:  Aleksandr A Rubel; Tatyana A Ryzhova; Kirill S Antonets; Yury O Chernoff; Alexey Galkin
Journal:  Prion       Date:  2013-10-23       Impact factor: 3.931

Review 2.  Application of yeast to studying amyloid and prion diseases.

Authors:  Yury O Chernoff; Anastasia V Grizel; Aleksandr A Rubel; Andrew A Zelinsky; Pavithra Chandramowlishwaran; Tatiana A Chernova
Journal:  Adv Genet       Date:  2020-05-04       Impact factor: 1.944

3.  Caprine PrP variants harboring Asp-146, His-154 and Gln-211 alleles display reduced convertibility upon interaction with pathogenic murine prion protein in scrapie infected cells.

Authors:  Eirini Kanata; Minas Arsenakis; Theodoros Sklaviadis
Journal:  Prion       Date:  2016-09-02       Impact factor: 3.931

Review 4.  Molecular pathology of human prion disease.

Authors:  Jonathan D F Wadsworth; John Collinge
Journal:  Acta Neuropathol       Date:  2010-08-08       Impact factor: 17.088

Review 5.  FRET Microscopy in Yeast.

Authors:  Michal Skruzny; Emma Pohl; Marc Abella
Journal:  Biosensors (Basel)       Date:  2019-10-11

6.  Potential approaches for heterologous prion protein treatment of prion diseases.

Authors:  Davis M Seelig; Patricia A Goodman; Pamela J Skinner
Journal:  Prion       Date:  2016       Impact factor: 3.931

7.  Impaired transmissibility of atypical prions from genetic CJDG114V.

Authors:  Ignazio Cali; Fadi Mikhail; Kefeng Qin; Crystal Gregory; Ani Solanki; Manuel Camacho Martinez; Lili Zhao; Brian Appleby; Pierluigi Gambetti; Eric Norstrom; James A Mastrianni
Journal:  Neurol Genet       Date:  2018-08-07

8.  Generation of human chronic wasting disease in transgenic mice.

Authors:  Zerui Wang; Kefeng Qin; Manuel V Camacho; Ignazio Cali; Jue Yuan; Pingping Shen; Justin Greenlee; Qingzhong Kong; James A Mastrianni; Wen-Quan Zou
Journal:  Acta Neuropathol Commun       Date:  2021-09-26       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.